Login / Signup

Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.

Hiromi TomonoHirokazu TaniguchiMinoru FukudaTakaya IkedaSeiji NagashimaKazumasa AkagiSawana OnoYasuhiro UmeyamaMidori ShimadaHiroshi GyotokuShinnosuke TakemotoYasushi HisamatsuRyotaro MorinagaRyuta TagawaRyosuke OgataYosuke DotsuHiroaki SenjuHiroshi SodaKatsumi NakatomiFumiko HayashiNanae SugasakiAkitoshi KinoshitaHiroshi Mukae
Published in: Thoracic cancer (2023)
This study was registered in the Japan Registry of Clinical Trials (no. jRCT s071210090) on November 4, 2021.
Keyphrases
  • small cell lung cancer
  • phase ii study
  • clinical trial
  • squamous cell carcinoma
  • open label
  • photodynamic therapy
  • cancer therapy